Page last updated: 2024-08-21

quinazolines and tretinoin

quinazolines has been researched along with tretinoin in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (43.75)29.6817
2010's9 (56.25)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grunt, TW1
Beak, SM; Jahng, Y; Kim, JA; Lee, YS; Paek, SH1
Ennishi, D; Hatake, K; Hino, N; Senoo, T; Sezaki, N; Terui, Y1
Bee, T; Black, CC; Dmitrovsky, E; Ewings, KE; Freemantle, SJ; Hattab, EM; Kelley, MR; Krizan, KA; Memoli, VA; Spinella, MJ; Vaseva, AV1
Hofer, HW; Pfeiffer, T; Schreiner, D; Stenzinger, A; Tag, C; Wimmer, M1
Duan, R; Grandis, JR; Johnson, DE; Jones, JE; Miranda, MB; Redner, RL; Thomas, SM1
Okkenhaug, K; Patton, DT; Rowan, WC; Soond, DR; Wilson, MD1
Bassano, C; Centritto, F; Flora, M; Fratelli, M; Garattini, E; Gardini, G; Guarnaccia, V; Paroni, G; Terao, M; Ubezio, P; Zanetti, A1
Fernández-Martínez, AB; Lucio Cazaña, FJ1
Fenaux, P; Galluzzi, L; Kepp, O; Kroemer, G; Lainey, E; Micol, JB; Sukkurwala, AQ; Wolfromm, A1
Navakauskiene, R; Savickiene, J; Stirblyte, I; Treigyte, G; Valiuliene, G1
Bolis, M; Fisher, JN; Fratelli, M; Garattini, E; Gianni, M; Goodall, GJ; Kurosaki, M; Lupi, M; Paroni, G; Terao, M; Tsykin, A; Zanetti, A1
Berardino, BG; Caramelo, JJ; Enriqué Steinberg, JH; Fiszbein, A; Giono, LE; Kornblihtt, AR; Pietrasanta, LI; Quaglino, A; Rossi, M; Schor, IE; Sigaut, L; Srebrow, A; von Bilderling, C1
Noy, N; Vreeland, AC; Zhang, W1
Amrouche, K; Jamin, C1

Reviews

2 review(s) available for quinazolines and tretinoin

ArticleYear
[Molecular target therapy for malignant tumors].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2005, Feb-20, Volume: 94 Suppl

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Benzamides; Clinical Trials as Topic; ErbB Receptors; Fusion Proteins, bcr-abl; Gefitinib; Hematologic Neoplasms; Humans; Imatinib Mesylate; Intracellular Signaling Peptides and Proteins; Neoplasms; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Rituximab; Signal Transduction; Trastuzumab; Tretinoin

2005
Influence of drug molecules on regulatory B cells.
    Clinical immunology (Orlando, Fla.), 2017, Volume: 184

    Topics: Adrenal Cortex Hormones; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; B-Cell Activating Factor; B-Lymphocytes, Regulatory; CD40 Antigens; Cytokines; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Pyrroles; Quinazolines; Receptors, Antigen, B-Cell; Semaphorins; Sirolimus; Toll-Like Receptors; Tretinoin; Vitamin D; Vitamins

2017

Other Studies

14 other study(ies) available for quinazolines and tretinoin

ArticleYear
Tyrphostins and retinoids cooperate during inhibition of in vitro growth of ovarian cancer cells.
    Cancer letters, 2003, Jan-28, Volume: 189, Issue:2

    Topics: Adenocarcinoma; Apoptosis; Benzothiazoles; Cell Division; Drug Resistance, Neoplasm; Drug Synergism; ErbB Receptors; Female; Humans; Neoplasm Proteins; Ovarian Neoplasms; Quinazolines; Receptor, ErbB-2; Tretinoin; Tumor Cells, Cultured; Tyrphostins

2003
Inhibition of UVA irradiation-modulated signaling pathways by rutaecarpine, a quinazolinocarboline alkaloid, in human keratinocytes.
    European journal of pharmacology, 2004, Sep-13, Volume: 498, Issue:1-3

    Topics: Acetylcysteine; Alkaloids; Blotting, Western; Cell Line; Cell Survival; Enzyme Activation; Gene Expression Regulation, Enzymologic; Humans; Hydrogen Peroxide; Indole Alkaloids; Keratinocytes; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Quinazolines; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tretinoin; Ultraviolet Rays

2004
A case of acute promyelocytic leukemia during gefitinib treatment.
    International journal of hematology, 2006, Volume: 84, Issue:3

    Topics: Adenocarcinoma; Antineoplastic Agents; Female; Gefitinib; Humans; Leukemia, Promyelocytic, Acute; Lung Neoplasms; Middle Aged; Neoplasms, Second Primary; Quinazolines; Remission Induction; Tretinoin

2006
Repression of cyclin D1 as a target for germ cell tumors.
    International journal of oncology, 2007, Volume: 30, Issue:2

    Topics: Antineoplastic Agents; Cell Differentiation; Cyclin D1; DNA Fragmentation; Enzyme Inhibitors; Erlotinib Hydrochloride; Gene Expression Regulation, Neoplastic; Humans; Neoplasms, Germ Cell and Embryonal; Quinazolines; Receptors, Retinoic Acid; RNA, Heterogeneous Nuclear; RNA, Small Interfering; Time Factors; Tretinoin

2007
Epidermal growth factor-, transforming growth factor-beta-, retinoic acid- and 1,25-dihydroxyvitamin D3-regulated expression of the novel protein PTPIP51 in keratinocytes.
    Cells, tissues, organs, 2006, Volume: 184, Issue:2

    Topics: Calcitriol; Cell Line; Cell Nucleus; Cytoplasm; Epidermal Growth Factor; Gene Expression Regulation; Humans; Keratinocytes; Mitochondrial Proteins; Protein Tyrosine Phosphatases; Quinazolines; RNA, Messenger; Transforming Growth Factor beta; Tretinoin

2006
Gefitinib potentiates myeloid cell differentiation by ATRA.
    Leukemia, 2008, Volume: 22, Issue:8

    Topics: Antineoplastic Agents; Bone Marrow Cells; Cell Differentiation; Drug Synergism; Gefitinib; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Quinazolines; Tretinoin

2008
The PI3K p110δ regulates expression of CD38 on regulatory T cells.
    PloS one, 2011, Mar-01, Volume: 6, Issue:3

    Topics: Adenine; ADP-ribosyl Cyclase 1; Animals; Cell Proliferation; Class I Phosphatidylinositol 3-Kinases; Forkhead Transcription Factors; Gene Expression Profiling; Gene Expression Regulation; Genome; Lymphocyte Subsets; Mice; Phosphatidylinositol 3-Kinases; Quinazolines; RNA, Messenger; T-Lymphocytes, Regulatory; Tretinoin

2011
Synergistic antitumor activity of lapatinib and retinoids on a novel subtype of breast cancer with coamplification of ERBB2 and RARA.
    Oncogene, 2012, Jul-19, Volume: 31, Issue:29

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Drug Synergism; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Amplification; Humans; Lapatinib; Phosphorylation; Quinazolines; Receptor, ErbB-2; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Smad3 Protein; Transcription, Genetic; Transcriptome; Transforming Growth Factor beta; Tretinoin

2012
Epidermal growth factor receptor transactivation by intracellular prostaglandin E2-activated prostaglandin E2 receptors. Role in retinoic acid receptor-β up-regulation.
    Biochimica et biophysica acta, 2013, Volume: 1833, Issue:9

    Topics: Cell Line, Tumor; Dinoprostone; Enzyme Inhibitors; ErbB Receptors; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Keratolytic Agents; Kidney Tubules, Proximal; Phosphorylation; Quinazolines; Receptors, Prostaglandin E; Receptors, Retinoic Acid; Transcriptional Activation; Tretinoin; Tyrphostins; Up-Regulation; Vascular Endothelial Growth Factor A

2013
EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cells.
    Cell cycle (Georgetown, Tex.), 2013, Sep-15, Volume: 12, Issue:18

    Topics: Antigens, CD34; CD11b Antigen; Cell Cycle Checkpoints; Cell Differentiation; Cholecalciferol; ErbB Receptors; Erlotinib Hydrochloride; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinase 14; Phosphorylation; Protein Kinase Inhibitors; Quinazolines; src-Family Kinases; Tretinoin; Tumor Cells, Cultured

2013
Euchromatic histone methyltransferase 2 inhibitor, BIX-01294, sensitizes human promyelocytic leukemia HL-60 and NB4 cells to growth inhibition and differentiation.
    Leukemia research, 2014, Volume: 38, Issue:7

    Topics: Azepines; Cell Differentiation; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Histocompatibility Antigens; Histone-Lysine N-Methyltransferase; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Quinazolines; Tretinoin

2014
MicroRNA networks regulated by all-trans retinoic acid and Lapatinib control the growth, survival and motility of breast cancer cells.
    Oncotarget, 2015, May-30, Volume: 6, Issue:15

    Topics: Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Carrier Proteins; Cell Growth Processes; Cell Line, Tumor; Cell Movement; Female; Humans; Lapatinib; MicroRNAs; Phosphoinositide Phospholipase C; Polymerase Chain Reaction; Protein Serine-Threonine Kinases; Quinazolines; Receptor, ErbB-2; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Tretinoin

2015
Alternative Splicing of G9a Regulates Neuronal Differentiation.
    Cell reports, 2016, 03-29, Volume: 14, Issue:12

    Topics: Alternative Splicing; Animals; Azepines; Brain; Cell Differentiation; Cell Line; Cell Nucleus; Exons; Fluorescence Resonance Energy Transfer; Genes, Reporter; HeLa Cells; Histone-Lysine N-Methyltransferase; Histones; Humans; Methylation; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Neurons; Protein Isoforms; Quinazolines; Real-Time Polymerase Chain Reaction; RNA Interference; RNA Precursors; RNA, Small Interfering; Tretinoin

2016
RNA-binding protein HuR regulates nuclear import of protein.
    Journal of cell science, 2016, 11-01, Volume: 129, Issue:21

    Topics: Active Transport, Cell Nucleus; Animals; Apoproteins; beta Karyopherins; Cell Nucleus; ELAV-Like Protein 1; Endoplasmic Reticulum; HEK293 Cells; Humans; Karyopherins; MCF-7 Cells; Mice; Nuclear Proteins; Quinazolines; Receptors, Retinoic Acid; RNA Stability; RNA, Messenger; Tretinoin

2016